Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1981-4-21
|
pubmed:abstractText |
In the present investigation, the neuropharmacology of 1,3 butanediol (1,3-BD) was compared with that of ethanol. Acute i.p. administration of equimolar doses of 1,3-BD or ethanol to rats impaired the aerial righting reflex, attenuated the suppressive effect of punishment on drinking behavior, lowered blood pressure, caused a concomitant reduction in the content of guanosine 3',5'-monophosphate in the cerebellum and reduced ethanol withdrawal reactions. Although these data suggested that ethanol and 2,3-BD were of similar potency, the brain content of 1,3-BD was only 33% of that of ethanol after treatment with equimolar doses, suggesting a greater central nervous system (CNS) potency for 1,3-BD. In rats treated chronically with ethanol to produce physical dependence, 1,3-BD was more potent than ethanol in inhibiting the hyperexcitability observed upon ethanol withdrawal. Furthermore, chronic administration and withdrawal of 1,3-BD caused CNS hyperexcitability in rats that was characteristic of physical dependence. Despite these similarities, there were clear differences in the actions of ethanol and 1,3-BD. In mice, locomotor stimulation caused by ethanol was not observed after 1,3-BD. Furthermore, while 1,3-BD did not alter the concentration of luteinizing hormone in plasma, equivalent doses of ethanol markedly reduced the concentration of this hormone. These data indicate that like ethanol, 1,3-BD depresses CNS activity and induces physical dependence, but has less effect on plasma luteinizing hormone concentration than ethanol.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Butylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Chlordiazepoxide,
http://linkedlifedata.com/resource/pubmed/chemical/Ethanol,
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Nucleotides, Cyclic
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
216
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
306-14
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7193248-Animals,
pubmed-meshheading:7193248-Behavior, Animal,
pubmed-meshheading:7193248-Blood Pressure,
pubmed-meshheading:7193248-Brain,
pubmed-meshheading:7193248-Butylene Glycols,
pubmed-meshheading:7193248-Cerebellum,
pubmed-meshheading:7193248-Chlordiazepoxide,
pubmed-meshheading:7193248-Dose-Response Relationship, Drug,
pubmed-meshheading:7193248-Ethanol,
pubmed-meshheading:7193248-Humans,
pubmed-meshheading:7193248-Luteinizing Hormone,
pubmed-meshheading:7193248-Male,
pubmed-meshheading:7193248-Motor Activity,
pubmed-meshheading:7193248-Movement,
pubmed-meshheading:7193248-Nucleotides, Cyclic,
pubmed-meshheading:7193248-Rats,
pubmed-meshheading:7193248-Substance Withdrawal Syndrome
|
pubmed:year |
1981
|
pubmed:articleTitle |
Effects of acute and chronic 1,3-butanediol treatment on central nervous system function: a comparison with ethanol.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|